Correlation of body mass index and menopausal status with the intra-tumoral estrogen system in invasive breast cancer

References

• Reeves G K, Pirie K, Beral V, Green J, Spencer E, Bull D. Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study. BMJ 2007; 335(7630)1134
   PubMedGoogle Scholar
• Stephenson G D, Rose D P. Breast cancer and obesity: an update. Nutr Cancer 2003; 45(1)1–16
   PubMed Web of Science ®Google Scholar
• Harada N, Utsumi T, Takagi Y. Molecular and epidemiological analyses of abnormal expression of aromatase in breast cancer. Pharmacogenetics 1995; 5: S59–S64
   Google Scholar
• Suzuki T, Nakata T, Miki Y, Kaneko C, Moriya T, Ishida T, Akinaga S, Hirakawa H, Kimura M, Sasano H. Estrogen sulfotransferase and steroid sulfatase in human breast carcinoma. Cancer Res 2003; 63(11)2762–2770
   PubMed Web of Science ®Google Scholar
• Klinge C M. Estrogen receptor interaction with estrogen response elements. Nucleic Acids Res 2001; 29(14)2905–2919
   PubMed Web of Science ®Google Scholar
• Fukutomi T, Akashi-Tanaka S. Prognostic and predictive factors in the adjuvant treatment of breast cancer. Breast Cancer 2002; 9(2)95–99
   PubMedGoogle Scholar
• Roger P, Sahla M E, Mäkelä S, Gustafsson J A, Baldet P, Rochefort H. Decreased expression of estrogen receptor beta protein in proliferative preinvasive mammary tumors. Cancer Res 2001; 61(6)2537–2541
   PubMed Web of Science ®Google Scholar
• Lindberg M K, Movérare S, Skrtic S, Gao H, Dahlman-Wright K, Gustafsson J A, Ohlsson C. Estrogen receptor (ER)-beta reduces (ER)-alpha-regulated gene transcription, supporting a “ying yang” relationship between (ER)-alpha and (ER)-beta in mice. Mol Endocrinol 2003; 17(2)203–208
   PubMedGoogle Scholar
• Treeck O, Pfeiler G, Horn F, Federhofer B, Houlihan H, Vollmer A, Ortmann O. Novel estrogen receptor beta transcript variants identified in human breast cancer cells affect cell growth and apoptosis of COS-1 cells. Mol Cell Endocrinol 2007; 264(1–2)50–60
   Google Scholar
• Chong Y M, Colston K, Jiang W G, Sharma A K, Mokbel K. The relationship between the insulin-like growth factor-1 system and the oestrogen metabolising enzymes in breast cancer tissue and its adjacent non-cancerous tissue. Breast Cancer Res Treat 2006; 99(3)275–288
   Google Scholar
• Iwao K, Miyoshi Y, Egawa C, Ikeda N, Tsukamoto F, Noguchi S. Quantitative analysis of estrogen receptor-alpha and -beta messenger RNA expression in breast carcinoma by real-time polymerase chain reaction. Cancer 2000; 89(8)1732–1738
   Google Scholar
• Zaichuk T, Ivancic D, Scholtens D, Schiller C, Khan S A. Tissue-specific transcripts of human steroid sulfatase are under control of estrogen signaling pathways in breast carcinoma. J Steroid Biochem Mol Biol 2007; 105(1–5)76–84
   Google Scholar
• Saji S, Hirose M, Toi M. Clinical significance of estrogen receptor beta in breast cancer. Cancer Chemother Pharmacol 2005; 56(Suppl 1)21–26
   Google Scholar
• Poola I, Fuqua S A, De Witty R L, Abraham J, Marshallack J J, Liu A. Estrogen receptor alpha-negative breast cancer tissues express significant levels of estrogen-independent transcription factors, ERbeta1 and ERbeta5: potential molecular targets for chemoprevention. Clin Cancer Res 2005; 11(20)7579–7585
   PubMed Web of Science ®Google Scholar
• Mandusić V, Nikolić-Vukosavljević D, Tanić N, Kanjer K, Neskovic-Konstantinović Z, Celeketić D, Dimitrijević B. Expression of estrogen receptor beta wt isoform (ERbeta1) and ERbetaDelta5 splice variant mRNAs in sporadic breast cancer. J Cancer Res Clin Oncol 2007; 133(8)571–579
   Google Scholar
• Ståhlberg A, Åman P, Ridell B, Mostad P, Kubista M. A quantitative real-time PCR method for detection of B-Lymphocyte monoclonality by comparison of kappa and lambda Immunoglobulin Light Chain Expression. Clin Chem 2003; 49(1)51–59
   PubMed Web of Science ®Google Scholar
• Livak K J, Schmittgen T D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-ΔΔCt) method. Methods 2001; 25(4)402–408
   PubMed Web of Science ®Google Scholar
• Järvinen T A, Pelto-Huikko M, Holli K, Isola J. Estrogen receptor beta is coexpressed with ERalpha and PR and associated with nodal status, grade, and proliferation rate in breast cancer. Am J Pathol 2000; 156(1)29–35
   Web of Science ®Google Scholar
• Skliris G P, Munot K, Bell S M, Carder P J, Lane S, Horgan K, Lansdown M R, Parkes A T, Hanby A M, Markham A F, et al. Reduced expression of oestrogen receptor beta in invasive breast cancer and its re-expression using DNA methyl transferase inhibitors in a cell line model. J Pathol 2003; 201(2)213–220
   Google Scholar
• Saceda M, Lippman M E, Lindsey R K, Puente M, Martin M B. Role of an estrogen receptor-dependent mechanism in the regulation of estrogen receptor mRNA in MCF-7 cells. Mol Endocrinol 1989; 1782–1787
   Google Scholar
• Pasqualini J R, Chetrite G, Blacker C, Feinstein M C, Delalonde L, Talbi M, Maloche C. Concentrations of estrone, estradiol, and estrone sulfate and evaluation of sulfatase and aromatase activities in pre- and post-menopausal breast cancer patients. J Clin Endocrinol Metab 1996; 81(4)1460–1464
   PubMed Web of Science ®Google Scholar
• Yamamoto Y, Yamashita J, Toi M, Muta M, Nagai S, Hanai N, Furuya A, Osawa Y, Saji S, Ogawa M. Immunohistochemical analysis of estrone sulfatase and aromatase in human breast cancer tissues. Oncol Rep 2003; 10(4)791–796
   Google Scholar